Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus

Methicillin resistant Staphylococcus aureus (MRSA) causes serious infections in humans and becomes resistant to a number of antibiotics. Due to the emergence of antibiotic resistance strains, there is an essential need to develop novel drug targets to address the challenge of multidrug-resistant bacteria. In current study, the idea was to utilize the available genome or proteome in a subtractive genome analyses protocol to identify drug targets within two of the MRSA types, i.e., MRSA ST398 and MRSA 252. Recently, the use of subtractive genomic approaches helped in the identification and characterization of novel drug targets of a number of pathogens. Our protocol involved a similarity search between pathogen and host, essentiality study using the database of essential genes, metabolic functional association study using Kyoto Encyclopedia of Genes and Genomes database (KEGG), cellular membrane localization analysis and Drug Bank database. Functional family characterizations of the identified non homologous hypothetical essential proteins were done by SVMProt server. Druggability potential of each of the identified drug targets was also evaluated by Drug Bank database. Moreover, metabolic pathway analysis of the identified druggable essential proteins with KEGG revealed that the identified proteins are participating in unique and essential metabolic pathways amongst MRSA strains. In short, the complete proteome analyses by the use of advanced computational tools, databases and servers resulted in identification and characterization of few nonhomologous/hypothetical and essential proteins which are not homologous to the host genome. Therefore, these non-homologous essential targets ensure the survival of the pathogen and hence can be targeted for drug discovery.

[1]  Current status and recommendations on methicillin-resistant Staphylococcus aureus infection in Latin America. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  Ge Zhang,et al.  Rapid Detection of the Pandemic Methicillin-Resistant Staphylococcus aureus Clone ST 239, a Dominant Strain in Asian Hospitals , 2008, Journal of Clinical Microbiology.

[3]  G. Ippolito,et al.  Methicillin-resistant Staphylococcus aureus: the superbug. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  Cheryl A. Kerfeld,et al.  Using BLAST to Teach “E-value-tionary” Concepts , 2011, PLoS biology.

[5]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[6]  Yuki Moriya,et al.  KAAS: an automatic genome annotation and pathway reconstruction server , 2007, Nucleic Acids Res..

[7]  Sharmila Anishetty,et al.  Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis , 2005, Comput. Biol. Chem..

[8]  G. Archer,et al.  The Staphylococci in Human Disease , 1996 .

[9]  A. Butt,et al.  Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[10]  Meena Kishore Sakharkar,et al.  A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa , 2004, Silico Biol..

[11]  Sethi Pk,et al.  Definition of Potential Targets in Mycoplasma Pneumoniae Through Subtractive Genome Analysis , 2010 .

[12]  A. Butt,et al.  Comparative Genomics Analysis of Mycobacterium ulcerans for the Identification of Putative Essential Genes and Therapeutic Candidates , 2012, PloS one.

[13]  Steffen Heber,et al.  In silico prediction of yeast deletion phenotypes. , 2006, Genetics and molecular research : GMR.

[14]  Martin Ester,et al.  PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..

[15]  X. Chen,et al.  SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence , 2003, Nucleic Acids Res..

[16]  F. DeLeo,et al.  Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.

[17]  R. Brunham,et al.  Identification of Pyruvate Kinase in Methicillin-Resistant Staphylococcus aureus as a Novel Antimicrobial Drug Target , 2011, Antimicrobial Agents and Chemotherapy.

[18]  Marc K Hellerstein,et al.  Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery , 2008, Journal of Pharmacology and Experimental Therapeutics.

[19]  John J. Georrge,et al.  In silico identification of putative drug targets in Klebsiella pneumonia MGH78578 , 2011 .

[20]  Fred C Tenover,et al.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. , 2006, The Journal of infectious diseases.

[21]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[22]  Anil Kumar,et al.  In silico Identification of Candidate Drug and Vaccine Targets from Various Pathways in Neisseria gonorrhoeae , 2009, Silico Biol..

[23]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[24]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[25]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[26]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[27]  Yan Lin,et al.  DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes , 2008, Nucleic Acids Res..

[28]  A Crowther,et al.  Three-day and ten-day chemotherapy for urinary tract infections in general practice. , 1976, British medical journal.

[29]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[30]  B. Maigret,et al.  Comparative genomics allowed the identification of drug targets against human fungal pathogens , 2011, BMC Genomics.

[31]  Stephen C. J. Parker,et al.  Towards the identification of essential genes using targeted genome sequencing and comparative analysis , 2006, BMC Genomics.

[32]  D. K. Sharma,et al.  Metabolic Pathway Analysis of S. Pneumoniae: an in silico Approach towards Drug-Design , 2007, J. Bioinform. Comput. Biol..

[33]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[34]  Preeti Gupta,et al.  In silico Identification of Putative Drug Targets from Different Metabolic Pathways of Aeromonas hydrophila , 2008, Silico Biol..

[35]  Adam Godzik,et al.  Clustering of highly homologous sequences to reduce the size of large protein databases , 2001, Bioinform..

[36]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[37]  Michael Y. Galperin,et al.  Searching for drug targets in microbial genomes. , 1999, Current opinion in biotechnology.

[38]  R. Knox,et al.  “Celbenin” - resistant Staphylococci , 1961 .

[39]  Eduardo P C Rocha,et al.  Essentiality, not expressiveness, drives gene-strand bias in bacteria , 2003, Nature Genetics.

[40]  A. Butt,et al.  Homology modeling, comparative genomics and functional annotation of Mycoplasma genitalium hypothetical protein MG_237 , 2011, Bioinformation.

[41]  Hong-Yu Ou,et al.  EG: a database of essential genes , 2004, Nucleic Acids Res..

[42]  Deepak Perumal,et al.  Differential Genome Analyses of Metabolic Enzymes in Pseudomonas aeruginosa for Drug Target Identification , 2007, Silico Biol..

[43]  R. Southgate,et al.  Penem inhibitors of bacterial signal peptidase , 1995 .

[44]  A. N. Sarangi,et al.  Genome subtraction for novel target definition in Salmonella typhi , 2009, Bioinformation.

[45]  H. Gresham,et al.  The genomic aspect of virulence, sepsis, and resistance to killing mechanisms in Staphylococcus aureus , 2002, Current infectious disease reports.

[46]  Ali A. Minai,et al.  Investigating the predictability of essential genes across distantly related organisms using an integrative approach , 2010, Nucleic acids research.

[47]  U. Amineni,et al.  In silico identification of common putative drug targets in Leptospira interrogans , 2010, Journal of chemical biology.

[48]  M. Kanehisa,et al.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus , 2001, The Lancet.

[49]  A. Chakraborty,et al.  Identification of potential targets in Staphylococcus aureus N315 using computer aided protein data analysis , 2013, Bioinformation.

[50]  Anirban Dutta,et al.  In Silico Identification of Potential Therapeutic Targets in the Human Pathogen Helicobacter Pylori , 2006, Silico Biol..

[51]  L. Nicolle.  Community-acquired MRSA: a practitioner's guide , 2006, Canadian Medical Association Journal.

[52]  F. Lowy.  Staphylococcus aureus infections. , 2009, The New England journal of medicine.

[53]  A. Friedrich,et al.  Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals , 2009, European Journal of Clinical Microbiology & Infectious Diseases.